The Morning Call
Research sites around South Africa are launching a major study to test the efficacy of a vaccine (HVTN 702) to prevent HIV infection. On Wednesday 30 November, some of the first of 5,400 volunteers to be enrolled in the study will receive their initial injections. the only current HIV vaccine efficacy trial in the world and is being conducted solely in South Africa. It has been seven years since the world last saw the start of an efficacy trial of an HIV vaccine.
01:02
Pics of the day: May 2, 2024
01:55
South Africa marks Freedom Day ahead of tough general election
02:20
South Africa to mark 30 years of freedom amid inequality and tense election ahead
Go to video
Repatriated South African apartheid-era artworks on display to celebrate 30 years of democracy
Go to video
Botswana rejects controversial UK proposal on asylum-seekers
01:10
Springboks confirm their Test fixture list for the rest of the year